Pharmacokinetics of Subcutaneously-administered CBX129801, A Long-acting Synthetic C-Peptide in Patients with Type 1 Diabetes Mellitus

Purpose:

To assess the pharmacokinetics (PK) of CBX129801, a long-acting synthetic C-peptide, following
subcutaneous (SC) injection in patients with type 1 diabetes mellitus (T1DM).